A Randomised, Double-blind, Placebo-controlled Phase IIb Trial to Test FLU-v Vaccine
Clinical trial NCT02962908 · COMPLETED
Trial details
- NCT number
- NCT02962908
- Sponsor
- PepTcell Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2017-07-18
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.